Merz Aesthetics
Merz Aesthetics, the standalone aesthetics arm of family-owned Merz Group, develops and sells injectables (XEOMIN, RADIESSE, Belotero), energy-based devices (Ultherapy PRIME, Cellfina, SalTFacial, DeScribe PFD Patch), and the Neocutis professional skincare line to certified healthcare professionals in 90+ countries through a B2B2C distribution model.
- Company typePrivate
- Founded1908
- HeadquartersFranksville, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Merz Aesthetics does
Merz Aesthetics is the world's largest dedicated medical aesthetics business and operates as the standalone aesthetics arm of family-owned Merz Group, founded in Frankfurt in 1908. The company develops, manufactures, and commercializes a multi-modality portfolio spanning injectables (XEOMIN, a double-purified incobotulinumtoxinA; RADIESSE, a calcium hydroxylapatite biostimulator; and Belotero Balance, a hyaluronic acid dermal filler), energy-based medical devices (the FDA-cleared Ultherapy PRIME microfocused ultrasound platform with real-time visualization, the Cellfina System for cellulite, the SalTFacial aesthetic ultrasound and LED phototherapy system, and the DeScribe PFD Patch for laser-assisted tattoo removal), and the Neocutis professional skincare line powered by proprietary peptide and bioactive technologies (MPC, Melaplex, Rosaplex, Vitaplex C, and CPM). Multiple flagship products hold FDA first-and-only or category-leading claims, including RADIESSE as the only regenerative biostimulator approved in the U.S. for both face and body (250+ scientific publications) and Cellfina's five-year FDA-cleared cellulite duration. R&D output extends to proprietary manufacturing processes (XTRACT double-purification), patented formulations (multiple U.S. patents covering each product line), and category-leading clinical evidence (96–98% patient satisfaction across RADIESSE and XEOMIN).
Merz Aesthetics generates revenue through a B2B2C model: products are prescription-only or HCP-administered medical devices distributed exclusively through board-certified dermatologists, plastic surgeons, aesthetic physicians, and licensed clinics, accessed via a global field-sales organization, a certified-clinic network (e.g., PRIME-certified clinics for Ultherapy), and provider-finder digital tools on each brand website. The Neocutis professional skincare and accessories (e.g., the redesigned Belotero ergonomic syringe) are sold quote-based through medical practices; public pricing is not disclosed, though one consumer-adjacent SKU, the Neocutis MICRO-FIRM Rejuvenating Complex, carries a $135 MSRP. Multichannel consumer demand is driven by celebrity ambassadors (Salma Hayek Pinault for Ultherapy PRIME; Demi Lovato, Christina Aguilera, Teyana Taylor, and Joe Jonas for XEOMIN; Christie Brinkley in past Ultherapy campaigns; Scha Alyahya in Malaysia), the Xperience+ patient loyalty program, and event-based HCP engagement including 16 scientific posters presented at IMCAS World Congress 2026 and the "Ahead of the Curve" symposium.
The company is privately held by Merz Group and headquartered in Raleigh, North Carolina, with commercial operations in 90+ countries spanning North America, Latin America (approximately 15% of global revenue, including a São Paulo regional headquarters), Europe, the Middle East, and Asia-Pacific (including newly entered China). Leadership comprises CEO Bob Rhatigan (also CEO, Americas), Patrick Urban as President of North America, CSO Samantha Kerr, CFO Alana Sine, and VP of Global Medical Affairs Terri L. Phillips, MD. Workforce size is in the 1,001–5,000 range; the company has been recognized for workplace culture through repeated Fortune Best Workplaces in Healthcare and Top Employer USA certifications, and for the fourth consecutive year on the Best Workplaces in Korea list.
Merz Aesthetics firmographics
Firmographics- Name
- Merz Aesthetics
- Legal name
- Merz North America, Inc.
- Website
- https://merzaesthetics.com
- Company type
- Private
- Founded year
- 1908
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Merz Aesthetics, the standalone aesthetics arm of family-owned Merz Group, develops and sells injectables (XEOMIN, RADIESSE, Belotero), energy-based devices (Ultherapy PRIME, Cellfina, SalTFacial, DeScribe PFD Patch), and the Neocutis professional skincare line to certified healthcare professionals in 90+ countries through a B2B2C distribution model.
- Ownership category
- akta.pro rank
Merz Aesthetics industry classification
Industry- Product category
- Medical Aesthetics
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where Merz Aesthetics is headquartered
LocationHeadquarters
- HQ city
- Franksville
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Merz Aesthetics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations
Revenue model
- Aesthetic Injectables: Revenue from neuromodulators (XEOMIN), dermal fillers (Belotero, RADIESSE), and biostimulators sold to healthcare professionals and clinics. Products are prescription-only medical devices administered by trained practitioners. Latin America contributes approximately 15% of Merz's global revenue.
- Medical Devices: Revenue from energy-based devices including Ultherapy PRIME ultrasound system for non-invasive skin lifting. Device sales and consumables/accessories to certified treatment providers.
- Skincare Products: Professional skincare line including Neocutis products (MPC-powered formulations) sold exclusively through medical practices and skincare providers. Products include BIO-CREAM, BIO-GEL, LUMIÈRE, MICRO-ESSENTIALS line, and post-treatment solutions.
- Device Accessories: Revenue from accessory products including the ergonomically redesigned Belotero syringe with improved haptics and precision, and DeScribe PFD Patch for laser-assisted tattoo removal.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Neocutis MICRO-FIRM Neck & Décolleté Rejuvenating Complex - Professional skincare |
| Other | Pay-as-you-go | RADIESSE treatment pricing - quote-based through providers |
| Subscription | Monthly | XEOMIN treatments - Xperience+ patient loyalty program |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Merz Aesthetics product offering
Product offeringCore offering
Merz Aesthetics manufactures and sells a comprehensive portfolio of medical aesthetics products to healthcare professionals, including neuromodulators (XEOMIN), dermal fillers and biostimulators (RADIESSE, Belotero), energy-based devices (Ultherapy PRIME microfocused ultrasound, Cellfina, SaltFacial), and the Neocutis professional skincare line. Products are prescription-only or administered exclusively by licensed practitioners through certified clinics across 90+ countries.
Product overview
Merz Aesthetics operates as the world's largest dedicated medical aesthetics business with more than 115 years of history, offering a comprehensive portfolio of injectable products, medical devices, and skincare solutions. The product portfolio spans three main categories: Injectables including XEOMIN (botulinum toxin with XTRACT Technology), RADIESSE/RADIESSE(+) (calcium hydroxylapatite biostimulator), and BELOTERO Balance/BELOTERO Balance(+) (hyaluronic acid fillers); Medical Devices including Ultherapy PRIME (FDA-cleared microfocused ultrasound with real-time visualization), Cellfina System (minimally invasive cellulose treatment), and Describe PFD Patch (laser-assisted tattoo removal accessory); and Skincare through the Neocutis brand featuring multiple sub-lines (MICRO Essential, Lumière, BIO, NEO, JOURNÉE, HYALIS) powered by proprietary technologies including MPC, Melaplex, Rosaplex, and Vitaplex C. The company is family-owned with global headquarters in Raleigh, NC and commercial presence in 90 countries worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- XEOMIN: Double-purified neurotoxin (incobotulinumtoxinA) for treatment of upper facial lines - forehead lines, frown lines, and crow's feet
- RADIESSE
- Belotero
- Ultherapy
- Neocutis
- Cellfina
- DeScribe PFD Patch
- SalTFacial
- Xperience+
- Merz Aesthetics Exchange (MAX)
Products and services
- XEOMIN (incobotulinumtoxinA) Double-purified botulinum toxin type A neurotoxin, FDA-approved for simultaneous treatment of upper facial lines (forehead lines, frown lines, and crow's feet). Uses proprietary XTRACT Technology for purification and contains only three ingredients.
- RADIESSE Regenerative biostimulator dermal filler composed of calcium hydroxylapatite. FDA-approved for facial wrinkles/folds, volume loss in hands, jawline contour improvement, and décolleté wrinkles. Stimulates natural collagen and elastin production with results lasting up to two years.
- RADIESSE (+) Calcium hydroxylapatite dermal filler with lidocaine for improved patient comfort. Used for smoothing moderate to severe facial wrinkles and folds, correcting volume loss in hands, and improving moderate to severe loss of jawline contour in adults over 21 years.
- BELOTERO Balance Hyaluronic acid dermal filler indicated for injection into mid-to-deep dermis for correction of moderate-to-severe facial wrinkles and folds such as nasolabial folds. Uses cohesive polydensified matrix (CPM) technology.
- BELOTERO Balance (+) with Lidocaine Lidocaine-formulated version of BELOTERO Balance hyaluronic acid filler for enhanced patient comfort during treatment of moderate-to-severe facial wrinkles and folds.
- Ultherapy PRIME FDA-cleared microfocused ultrasound treatment with real-time visualization for non-invasive skin lifting and tightening. Indicated for face, neck, brow, décolleté, arms, and abdomen. The only ultrasound device with integrated real-time visualization.
- Cellfina System Minimally invasive FDA-cleared procedure for improvement of cellulite appearance on buttocks and thighs. Uses vacuum-assisted precise tissue release technology with results lasting up to five years.
- DeScribe PFD Patch Accessory for laser-assisted tattoo removal. First and only FDA-cleared accessory for this indication, cleared for use with multiple laser types and wavelengths.
- Neocutis MICRO Essential Line Skincare line powered by Micro Protein Complex (MPC) technology. Includes MICRO DAY, MICRO NIGHT, MICRO EYES, MICRO SERUM, and MICRO BODY products formulated with lab-created peptides for anti-aging benefits including elasticity improvement.
- Neocutis Lumière Line Bio-restorative eye cream line for anti-aging skincare. Includes Lumière and Lumière Riche variants, recognized multiple times with InStyle Best Beauty Buy awards.
- Neocutis BIO Line Bio-restorative skincare products including BIO SERUM, BIO CREAM, BIO GEL, and BIO BODY. Features firming, moisturizing, and skin restoration properties.
- Neocutis NEO Line Post-treatment and targeted skincare line including NEO FIRM, NEO RESTORE, NEO RENEW, and NEO CLEANSE. Formulated for post-procedure care and specific skin concerns.
- Neocutis PERLE Skin brightening cream powered by Melaplex technology for addressing uneven skin tone and pigmentation concerns.
- Neocutis PÊCHE Redness control product powered by Rosaplex technology for sensitive skin and rosacea concerns.
- Neocutis RéACTIVE+ Anti-oxidant serum powered by Vitaplex C technology for protecting skin against environmental damage and oxidative stress.
- Neocutis MICRO FIRM Neck & Décolleté Rejuvenating Complex Skincare product for neck and décolleté rejuvenation. Formulated with Micro Protein Complex (MPC) technology, a peptide blend to help rejuvenate skin elasticity.
- Ultherapy Mask - PDRN Peptide Radiance At-home hydrogel mask designed for post-treatment hydration and skin recovery. Combines PDRN derived from salmon DNA, multi-molecular hyaluronic acid, and 20 peptides. Clinical testing showed up to 68% moisture increase and 23% skin barrier strengthening after four days. Available exclusively through PRIME certified clinics in Malaysia.
- The SaltFacial Aesthetic ultrasound device providing therapeutic deep heat via ultrasound diathermy. Includes LED phototherapy module with blue light mode for treatment of mild to moderate inflammatory acne vulgaris.
- Xperience+ Patient Loyalty Program Patient loyalty program enabling patients to earn rewards on XEOMIN and additional Merz Aesthetics treatments. Patients can create accounts and access rewards through xperiencemerz.com.
Quantifiable outcome
- 98% patient satisfaction rate with RADIESSE treatments
- +7 more outcomes
Companies that use Merz Aesthetics
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles1 record
Merz Aesthetics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
Feature6 records
Merz Aesthetics partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered regional, flagship, minor, core and strategic.
- Scha AlyahyaregionalMalaysian actress appointed as Malaysia's first Ultherapy PRIME Brand Ambassador. Anchors the 'See My Skin, Lift My Way' 2026 campaign in Southeast Asia market. Launched at Ultherapy PRIME Soirée in Kuala Lumpur.
- Korean Dermatology/Plastic Surgery ClinicsregionalMerz Aesthetics Korea hosted 'Radius X Belotero Revive Skin Booster Conference' at Mayfield Hotel Seoul, bringing together medical professionals for academic sessions on skin booster treatments, mechanisms, and clinical case studies.
- North Carolina CourageflagshipMulti-year sponsorship extension (6 total years) making Merz Aesthetics front-of-jersey sponsor for fourth consecutive year. Includes 'Woman of the Match' award presented at home matches to celebrate women in Triangle community who empower others. Partnership focuses on women's empowerment and community programming on and off the field.
- NewBeauty (Step Beyond the Scale)minorGLP-1 education platform partnership supporting individuals interested in weight-loss medications and aesthetic changes following significant weight loss. Merz Aesthetics aims to address aesthetic concerns related to weight-loss treatments.
- Salma Hayek PinaultflagshipFirst-ever global brand ambassador for Ultherapy PRIME, the non-invasive skin lifting treatment. Announced April 2025 to anchor the brand's global marketing initiatives and reach new audiences seeking natural-looking aesthetic results.
- Demi LovatocoreBrand partner for XEOMIN 'Beauty On Your Terms' multi-year campaign. Part of broader celebrity ambassador strategy including Christina Aguilera, Teyana Taylor, and Joe Jonas for XEOMIN brand.
- AccuVeinstrategicExclusive partnership offering AV500 vein visualization device to Merz Aesthetics customers in the US. Enhances treatment precision and patient comfort during injectable procedures by visualizing veins.
- Christina AguileracoreXEOMIN 'Beauty On Your Terms' campaign brand partner. Celebrity ambassador helping drive awareness for the neurotoxin brand among consumers seeking aesthetic treatments.
- Christie Brinkleycore'Milestones of Me' campaign featuring Ultherapy. Supermodel and actress partnered with Merz to encourage women to celebrate life milestones while feeling their best through aesthetic treatments.
Scale indicators14 records
Recent moves8 records
Expansion highlights8 records
Merz Aesthetics competitors and assessment
Company assessmentDirect peers
- Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is the dominant player in medical aesthetics with Botox (neuromodulator), Juvéderm (HA filler family), CoolSculpting (body contouring), and SkinMedica skincare. Directly competes with XEOMIN, Belotero, and the broader Merz injectables portfolio, with substantially larger commercial scale.
- Galderma: Galderma is a pure-play dermatology and aesthetics company offering Dysport (competing neuromodulator), Restylane (HA filler), Sculptra (PLLA biostimulator directly competing with RADIESSE), and Alastin skincare. Direct portfolio overlap with Merz across injectables, biostimulators, and professional skincare; publicly listed (SIX: GALD) with comparable global presence.
- Evolus: Evolus commercializes Jeuveau (prabotulinumtoxinA), a competing neuromodulator positioned as a value alternative to Botox and XEOMIN. Focused exclusively on the aesthetic neurotoxin category overlapping with Merz's XEOMIN.
- Revance Therapeutics: Revance developed DAXXIFY (daxibotulinumtoxinA), a long-duration neuromodulator competing with XEOMIN/Botox, and the RHA Collection of resilient HA fillers competing with Belotero. Direct competitor in both neuromodulator and filler categories.
Emerging players
- Hugel: South Korean aesthetics company producing Botulax (botulinum toxin) and a portfolio of HA fillers, with rapidly expanding international presence including the U.S. market. Emerging competitor in the same neuromodulator and filler categories as Merz, particularly relevant given Merz's Asia-Pacific focus.
- BTL Industries: BTL markets EMSCULPT (muscle building), EMTONE (cellulite), and EMFACE (facial muscle + skin treatment) — energy-based aesthetic devices targeting the same physician channel and patient base as Ultherapy PRIME. Comparable business model: device + consumables sold to medical aesthetics practices.
Broad incumbents
- Solta Medical (Bausch Health): Solta Medical, part of Bausch Health, markets Thermage (radiofrequency skin tightening) and Fraxel (fractional laser) — energy-based aesthetic devices competing in the same physician channel as Ultherapy PRIME. Broader incumbent in medical aesthetics devices with a wider technology portfolio.
- Cynosure (Hologic): Cynosure, owned by Hologic, markets a portfolio of laser, light-based, and radiofrequency aesthetic devices (e.g., PicoSure, TempSure) used by the same physician customer base as Ultherapy PRIME. Broader incumbent in the medical aesthetics device category.
Regional players
- Bloomage Biotechnology: Bloomage is China's largest hyaluronic acid manufacturer and a leading aesthetics brand (e.g., Hyaron, BM Muscle), dominating the domestic Chinese injectables market. Merz's late-2025 China launch directly competes against Bloomage's entrenched physician network and price tiering.
Others
- SkinCeuticals (L'Oréal): SkinCeuticals is L'Oréal's medical-grade professional skincare brand, sold through physician practices alongside Merz's Neocutis line. Comparable professional skincare distribution model and target customer base, though broader consumer-brand backing gives SkinCeuticals greater consumer marketing reach.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Merz Aesthetics social profiles
Digital presenceMerz Aesthetics compliance and trust
Trust signalCompliance11 records
Merz Aesthetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merz Aesthetics leadership team
Management profileNumber of profiles
Profiles9 records
Merz Aesthetics subsidiaries and ownership
Company hierarchySubsidiaries4 records
Merz Aesthetics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merz Aesthetics M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merz Aesthetics
What does Merz Aesthetics do?
Merz Aesthetics manufactures and sells a comprehensive portfolio of medical aesthetics products to healthcare professionals, including neuromodulators (XEOMIN), dermal fillers and biostimulators (RADIESSE, Belotero), energy-based devices (Ultherapy PRIME microfocused ultrasound, Cellfina, SaltFacial), and the Neocutis professional skincare line. Products are prescription-only or administered exclusively by licensed practitioners through certified clinics across 90+ countries.
Is Merz Aesthetics a public or private company?
Merz Aesthetics is a private company. It is classified as family owned and is currently operating.
When was Merz Aesthetics founded?
Merz Aesthetics was founded in 1908. It employs 1,001 to 5,000 people.
Where is Merz Aesthetics based?
Merz Aesthetics is headquartered in Franksville, United States, in the North America region.
How does Merz Aesthetics make money?
Four revenue lines are on record. Aesthetic Injectables are the primary driver. The others are medical Devices, skincare Products and device Accessories.
Who are Merz Aesthetics's main competitors?
Direct peers on record are Allergan Aesthetics (AbbVie), Galderma, Evolus and Revance Therapeutics. Emerging players are Hugel and BTL Industries. Broad incumbents are Solta Medical (Bausch Health) and Cynosure (Hologic). Bloomage Biotechnology is listed as a regional player. SkinCeuticals (L'Oréal) is listed as an others.
Does Merz Aesthetics have an API?
No public API is recorded for Merz Aesthetics.
What industry is Merz Aesthetics in?
Merz Aesthetics's product category is Medical Aesthetics. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3391 and its SIC code is 3841.